Metabolic reprogramming supports the invasive phenotype in malignant melanoma
- PMID: 26095603
- DOI: 10.1016/j.canlet.2015.06.006
Metabolic reprogramming supports the invasive phenotype in malignant melanoma
Abstract
Invasiveness is a hallmark of aggressive cancer like malignant melanoma, and factors involved in acquisition or maintenance of an invasive phenotype are attractive targets for therapy. We investigated melanoma phenotype modulation induced by the metastasis-promoting microenvironmental protein S100A4, focusing on the relationship between enhanced cellular motility, dedifferentiation and metabolic changes. In poorly motile, well-differentiated Melmet 5 cells, S100A4 stimulated migration, invasion and simultaneously down-regulated differentiation genes and modulated expression of metabolism genes. Metabolic studies confirmed suppressed mitochondrial respiration and activated glycolytic flux in the S100A4 stimulated cells, indicating a metabolic switch toward aerobic glycolysis, known as the Warburg effect. Reversal of the glycolytic switch by dichloracetate induced apoptosis and reduced cell growth, particularly in the S100A4 stimulated cells. This implies that cells with stimulated invasiveness get survival benefit from the glycolytic switch and, therefore, become more vulnerable to glycolysis inhibition. In conclusion, our data indicate that transition to the invasive phenotype in melanoma involves dedifferentiation and metabolic reprogramming from mitochondrial oxidation to glycolysis, which facilitates survival of the invasive cancer cells. Therapeutic strategies targeting the metabolic reprogramming may therefore be effective against the invasive phenotype.
Keywords: Melanoma; Metabolic reprogramming; Phenotype switch; S100A4; Warburg effect.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2.J Biol Chem. 2019 May 3;294(18):7516-7527. doi: 10.1074/jbc.RA118.004365. Epub 2019 Mar 18. J Biol Chem. 2019. PMID: 30885944 Free PMC article.
-
Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.J Cell Mol Med. 2016 May;20(5):825-35. doi: 10.1111/jcmm.12808. Epub 2016 Mar 1. J Cell Mol Med. 2016. PMID: 26928771 Free PMC article.
-
RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.Eur Rev Med Pharmacol Sci. 2013 Jun;17(12):1669-80. Eur Rev Med Pharmacol Sci. 2013. PMID: 23832737
-
Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.World J Surg Oncol. 2016 Jan 20;14(1):15. doi: 10.1186/s12957-016-0769-9. World J Surg Oncol. 2016. PMID: 26791262 Free PMC article. Review.
-
Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy.Cancer Lett. 2009 Jul 18;280(1):15-30. doi: 10.1016/j.canlet.2008.10.037. Epub 2008 Dec 6. Cancer Lett. 2009. PMID: 19059703 Review.
Cited by
-
The use of ketogenic diets in cancer patients: a systematic review.Clin Exp Med. 2021 Nov;21(4):501-536. doi: 10.1007/s10238-021-00710-2. Epub 2021 Apr 3. Clin Exp Med. 2021. PMID: 33813635 Free PMC article. Review.
-
Regulation of Tumor Progression by Programmed Necrosis.Oxid Med Cell Longev. 2018 Jan 31;2018:3537471. doi: 10.1155/2018/3537471. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29636841 Free PMC article. Review.
-
Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E.Cancer Res. 2017 Feb 1;77(3):613-622. doi: 10.1158/0008-5472.CAN-16-1298. Epub 2016 Nov 22. Cancer Res. 2017. PMID: 27879264 Free PMC article.
-
S100A4 in cancer progression and metastasis: A systematic review.Oncotarget. 2017 May 19;8(42):73219-73239. doi: 10.18632/oncotarget.18016. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069865 Free PMC article. Review.
-
FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.Oncotarget. 2016 Jul 26;7(30):47985-47997. doi: 10.18632/oncotarget.10103. Oncotarget. 2016. PMID: 27351131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials